Literature DB >> 18502427

Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model.

Wanfen Xiong1, Jason Mactaggart, Rebecca Knispel, Jennifer Worth, Zhen Zhu, Yulong Li, Yimin Sun, B Timothy Baxter, Jason Johanning.   

Abstract

Reactive oxygen species (ROS) are increased in human abdominal aortic aneurysms (AAA). NADPH oxidases are the predominant source of superoxide anion (O(2)(-)) in the vasculature. Inducible nitric oxide synthase (iNOS) produces a significant amount of nitric oxide (NO) during inflammatory processes. We hypothesized that ROS produced by NADPH oxidases and iNOS played an important role in aneurysm formation. We examined this hypothesis using selective blockade of NADPH oxidases and iNOS in a murine model of AAA. Mice, including C57BL/6, iNOS knockout (iNOS(-/-)) mice, and its background matched control (C57BL/6), underwent AAA induction by periaortic application of CaCl(2). Aortic diameter was measured at aneurysm induction and harvest. Beginning 1 week prior to aneurysm induction and continuing to aortic harvest 6 weeks later, one group of the C57BL/6 mice were treated with orally administered apocynin (NADPH oxidase inhibitor). Control mice were given water. The mean diameter and change in diameter of each group were compared with concurrent controls. Aortic levels of the NO metabolite, NO(x) (NO(2) and NO(3)), were significantly increased in CaCl(2)-treated wild type mice. INOS(-/-) mice were partly resistant to aneurysm induction. This was associated with reduced expression of matrix metalloproteinase (MMP)-2 and MMP-9 and decreased production of NO(x) in the aortic tissues. Inhibition of NADPH oxidase by apocynin also blocked aneurysm formation. In conclusion, both iNOS deficiency and NADPH oxidase inhibition suppressed aneurysm formation in association with decreased NO(x) levels. These studies suggest that both NADPH oxidase and iNOS pathways contribute to ROS production and AAA development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502427      PMCID: PMC2646364          DOI: 10.1016/j.atherosclerosis.2008.03.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.

Authors:  Q W Xie; H J Cho; J Calaycay; R A Mumford; K M Swiderek; T D Lee; A Ding; T Troso; C Nathan
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray.

Authors:  Noriyuki Yajima; Masahisa Masuda; Masaru Miyazaki; Nobuyuki Nakajima; Shu Chien; John Y-J Shyy
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

3.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; T Morodomi; J J Enghild; K Suzuki; A Yasui; I Nakanishi; G Salvesen; H Nagase
Journal:  Eur J Biochem       Date:  1990-12-27

4.  Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions.

Authors:  Natalia Kalinina; Alex Agrotis; Eduard Tararak; Yulia Antropova; Peter Kanellakis; Olga Ilyinskaya; Mark T Quinn; Vladimir Smirnov; Alex Bobik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

5.  Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.

Authors:  Damian N Meli; Stephan Christen; Stephen L Leib
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

6.  Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker.

Authors:  Junya Ejiri; Nobutaka Inoue; Takuro Tsukube; Takashi Munezane; Yutaka Hino; Seiichi Kobayashi; Ken-ichi Hirata; Seinosuke Kawashima; Shinobu Imajoh-Ohmi; Yoshitake Hayashi; Hiroshi Yokozaki; Yutaka Okita; Mitsuhiro Yokoyama
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

7.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 8.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

9.  Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury.

Authors:  Jian Zhang; Jan Schmidt; Eduard Ryschich; Martina Mueller-Schilling; Hardy Schumacher; Jens Rainer Allenberg
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

10.  Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model.

Authors:  Wanfen Xiong; Yong Zhao; Amy Prall; Timothy C Greiner; B Timothy Baxter
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

View more
  54 in total

Review 1.  Pathophysiology and epidemiology of abdominal aortic aneurysms.

Authors:  Ian M Nordon; Robert J Hinchliffe; Ian M Loftus; Matt M Thompson
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

2.  Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development.

Authors:  Uwe Raaz; Alexander M Zöllner; Isabel N Schellinger; Ryuji Toh; Futoshi Nakagami; Moritz Brandt; Fabian C Emrich; Yosuke Kayama; Suzanne Eken; Matti Adam; Lars Maegdefessel; Thomas Hertel; Alicia Deng; Ann Jagger; Michael Buerke; Ronald L Dalman; Joshua M Spin; Ellen Kuhl; Philip S Tsao
Journal:  Circulation       Date:  2015-04-22       Impact factor: 29.690

3.  Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.

Authors:  Jie Yu; Keisuke Morimoto; Wulan Bao; Zhenhai Yu; Yutaka Okita; Kenji Okada
Journal:  Surg Today       Date:  2015-12-13       Impact factor: 2.549

4.  Smooth muscle cells isolated from thoracic aortic aneurysms exhibit increased genomic damage, but similar tendency for apoptosis.

Authors:  Ceyda Acilan; Muge Serhatli; Omer Kacar; Zelal Adiguzel; Altug Tuncer; Mutlu Hayran; Kemal Baysal
Journal:  DNA Cell Biol       Date:  2012-08-07       Impact factor: 3.311

5.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

6.  Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm.

Authors:  Kin Lung Siu; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

7.  Evaluation of apoptotic molecular pathways for smooth muscle cells isolated from thoracic aortic aneurysms in response to oxidized sterols.

Authors:  Zelal Adiguzel; Nazli Arda; Omer Kacar; Muge Serhatli; Serpil Gezer Tas; Ahmet Tarik Baykal; Kemal Baysal; Ceyda Acilan
Journal:  Mol Biol Rep       Date:  2014-09-30       Impact factor: 2.316

Review 8.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

9.  On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm.

Authors:  J Pincemail; J O Defraigne; J P Cheramy-Bien; N Dardenne; A F Donneau; A Albert; N Labropoulos; N Sakalihasan
Journal:  Redox Rep       Date:  2012-06-21       Impact factor: 4.412

Review 10.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.